We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.40
Bid: 35.45
Ask: 36.10
Change: -0.40 (-1.12%)
Spread: 0.65 (1.834%)
Open: 35.80
High: 36.20
Low: 35.00
Prev. Close: 35.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Financial Stocks Recover On Plans To Head South

Thu, 11th Sep 2014 11:14

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
Standard Life, up 1.8%. The Edinburgh headquartered savings and investment business is seeing a second consecutive day of recovery following the negative shock the company received from a couple of polls that showed a sharp rise of support for the "Yes" campaign in the run up to the Scottish independence referendum on September 18. On Wednesday Standard Life moved to reassure investors by saying that it could transfer parts of its business out of Scotland.

Royal Bank of Scotland, up 1.3%; Lloyds Banking Group, up 1.2%. The two part-government owned, and heavily Scotland exposed, banks are also recovering some recent weakness after saying they have made contingency plans to move their headquarters to London in the event of the Scottish people voting in favour of a split from the UK in next week's independence referendum. "While the scale of potential change is currently unclear, we have contingency plans in place which include the establishment of new legal entities in England," Lloyds said in a statement.
-------
FTSE 100 LOSERS
-------
Next, down 1.7%. Shares of the UK's biggest clothing retailer by market share have slipped despite a solid set of interim results. Investors were underwhelmed following the group's stellar run of late. Next reported a 19% rise in pretax profit to GBP324.2 million for the first half of the year, as revenue rose to GBP1.85 billion from GBP1.68 billion. The retailer cited a range of factors including the improving UK economy and much better summer weather, although it kept most of its full-year outlook unchanged, having already raised it twice this year. "Against lofty expectations, Next has had a stellar first half, but numbers are a little short of consensus," says Investec analyst Alistair Davies.

Tesco, down 0.8%. The supermarket giant has been outshone Thursday by Morrisons, which raised its interim dividend by 5%, along with delivering half-year results broadly in line with expectations. The delivery on planned shareholder returns has surprised some given that Tesco decided to slash its dividend by 75% less than two weeks ago due to the ongoing pressures in the UK grocery sector. Following recent share price weakness and the newly raised dividend payment, Shore Capital calculates that Morrison currently offers investors a particularly high dividend yield of almost 8%. This may have encouraged some investors to switch their supermarket holdings Wednesday. Morrison shares spiked as much as 4% in early trade, but are currently close to flat.
-------
FTSE 250 WINNERS
-------
Ocado, up 4.1%. The grocery delivery business has seen a strong jump in its share price after saying that its sales in the 12 weeks to August 10 were up 23% to GBP231.9 million, against GBP189.2 million a year earlier. Retail sales in the period were up 16% to GBP218.5 million against GBP189.2 million last year. Average orders per week increased by 17% to 163,000, against 139,000 last year, but average order size was down by 1.7% to GBP111.64 against GBP113.54 in the corresponding period in 2013. The company said its trading momentum was solid in the period, but Chief Executive Tim Steiner said the retail environment at the moment was "challenging", owing to the "increased level of promotional activity and price reductions across the industry".

RPC Group, up 2.6%. The packaging company saw its share rise after saying it has reached a deal to sell its rigid-sheet businesses in Italy and Belgium for an undisclosed amount. RPC said the deals, along with the sale of its disposables trading business Tedeco-Gizeh GmbH in Germany, mark the end of the divestment portion of its "Fitter for the Future" programme. The two deals are expected to conclude towards the end of this month.
-------
FTSE 250 LOSERS
-------
Home Retail Group, down 6.6%. The DIY and general merchants retailer reported a mixed quarterly update that recorded a ninth consecutive quarter of like-for-like sales growth for Argos, but tepid growth at its Homebase DIY unit as sales of seasonal goods fell short of last year. The group sounded a little cautious as it said it expects to report a benchmark profit in line with market expectations for the full year, in the range of GBP122 million and GBP135 million, although, as always, this will depend on how Argos performs over the key Christmas trading period. "To meet that target, we need Argos to continue its current run rate, with like-for-like sales broadly around 3% and margins close to flat," Chief Executive John Walden told journalists Thursday.

Ashmore Group, down 6.3%. The emerging markets asset manager reported a 34% drop in full-year pretax profit, as it came under pressure due to emerging-market volatility, lower performance fees and the strength of the pound. Ashmore made GBP170.3 million pretax profit in the year ended June 30, compared with GBP257.6 million last year. It said GBP46.0 million was due to foreign exchange translation, while GBP30.1 million was due to lower performance fees as a consequence of the market sell-off in May and June 2013 and continued volatility throughout the first half of the financial year.

William Hill, down 1.3%. The bookmaker has suffered a downgrading to Neutral From Overweight by analysts at HSBC. The bank also lowered its price target for William Hill to 365p from 385p, although that still suggests a small upside from Wednesday quote of 344.20p.

Green King, down 1.1%. The pub company has had its price target trimmed by Goldman Sachs to 860p from 890p, which comes with a Neutral recommendation. The shares closed Wednesday at 797.5p. The move from Goldman comes after Green King reported decidedly weak sales growth in the first 18 weeks of its financial year on Wednesday.
-------
AIM ALL-SHARE WINNERS
-------
Elektron Technology, up 12%. The Cambridge-based technology company, which makes things like switches, connectors and monitoring and control products for scientific, medical, industrial and commercial use, saw its shares rise Thursday after it reported an underlying operating profit for the first half of its financial year. The company reported a narrowed operating loss of GBP0.4 million for the six months to end-July, compared with a GBP2.1 million loss a year, thanks to its cost cutting and as exceptional items, including restructuring expenses, impairments and some finance items, fell to GBP1.0 million, from GBP2.1 million. Excluding those items, its underlying operating profit rose to GBP0.6 million, from nothing a year earlier.

Solo Oil, up 10%. The exploration group saw its shares rise after saying that interpretation of newly acquired seismic data has extended the potential of the Ntorya appraisal area within the Ruvuma license in Tanzania, and it had further increased its resource estimate for the license by combining the Ntorya discovery with the adjacent Likonde prospect. Main market listed Aminex is also significantly higher, up 21%. Aminex owns 75% of the Ruvuma license and is its operator, while Solo Oil PLC owns the rest.

Patagonia Gold, up 8.9%. The gold miner reported record production from its Lomada de Leiva mine in August, extracting 2,961 ounces at a cash cost of USD625 per ounce. The company also said it is on target to achieve its production target of 3,000 ounces of gold per month by the end of the third quarter.
-------
AIM ALL-SHARE LOSERS
-------
Stilo International, down 25%. Shares in the software company have plunged after the group reported its pretax profit and revenue fell in the first half, though the company said the fall would be offset in the second half and said it would pay an interim dividend. Stilo said pretax profit in the six months to June 30 nearly halved to GBP39,000, from GBP72,000 a year earlier, as revenue fell to GBP617,000 from GBP733,000 in 2013. Stilo said the fall in sales was down to a reduction in OmniMark content conversion software licence sales, which it expects to be offset by increased sales of its Migrate cloud XML content conversion service in the second half. The group also said it took a hit to the tune of GBP430,000 by adverse foreign exchange.

SpaceandPeople, down 13%. Shares in experiential marketing and media company have dropped after the company issued another profit warning for 2014 as a host of its businesses failed to meet performance expectations. The group said the first half of 2014 had proven challenging for its business and said that, while some of its operations have traded in line with the revised expectations, others have proved disappointing in comparison to the revised forecasts. The company is now forecasting pretax profit of GBP500,000 to GBP700,000 for the year, compared to the GBP2.3 million it made for the full year in 2013.

Futura Medical, down 11%. The healthcare company reported a widening of its pretax loss to GBP1.6 million in the first half of the year from GBP1.0 million in the previous year, as revenue fell to GBP2,262 from GBP320,513, and administrative and research and development costs rose. Futura said that its fund raising of GBP12 million in March would support the clinical development of its earlier-stage product portfolio towards commercialisation.
-------
By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

Read more
3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
Wednesday 10 April 
Churchill China PLCFull Year Results
Futura Medical PLCFull Year Results
M&C Saatchi PLCFull Year Results
Marshalls PLCFull Year Results
Tesco PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Read more
6 Feb 2024 17:04

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

Read more
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
6 Feb 2024 10:08

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Read more
15 Jan 2024 14:59

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Read more
15 Jan 2024 08:35

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

Read more
7 Nov 2023 17:47

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Oct 2023 12:21

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

Read more
19 Oct 2023 14:17

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Read more
2 Oct 2023 14:22

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Read more
2 Oct 2023 12:13

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

Read more
18 Sep 2023 11:28

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Sep 2023 15:44

UK earnings, trading statements calendar - next 7 days

Tuesday 12 September 
Associated British Foods PLCTrading Statement
Cornerstone FS PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Digital 9 Infrastructure PLCHalf Year Results
Dowlais Group PLCHalf Year Results
Eleco PLCHalf Year Results
Equals Group PLCHalf Year Results
Feedback PLCFull Year Results
Fevertree Drinks PLCHalf Year Results
Gym Group PLCHalf Year Results
Harworth Group PLCHalf Year Results
hVIVO PLCHalf Year Results
IQE PLCHalf Year Results
Itaconix PLCHalf Year Results
JTC PLCHalf Year Results
Keywords Studios PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocean Harvest Technology Group PLCHalf Year Results
Property Franchise Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Smart Metering Systems PLCHalf Year Results
Wednesday 13 September 
abrdn Smaller Companies Income Trust PLCHalf Year Results
Argentex Group PLCHalf Year Results
Brave Bison Group PLCHalf Year Results
Burford Capital LtdHalf Year Results
CAB Payments Holdings PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Frontier Developments PLCFull Year Results
Made Tech Group PLCFull Year Results
On The Beach Group PLCTrading Statement
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Ricardo PLCFull Year Results
Star Energy Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.